The use of systemic anticancer chemotherapy is intrinsically limited by its toxicity. Whether
dealing with small molecules or biopharmaceuticals, after systemic administration, small …

Clinical practice guidelines (CPGs) translate evidence into recommendations to improve
patient care and outcomes. To provide an overview of schizophrenia CPGs, we conducted a …

The British Association for Psychopharmacology guidelines specify the scope and targets of
treatment for bipolar disorder. The third version is based explicitly on the available evidence …

Despite their widespread use, long-acting injectable (LAI) antipsychotics (APs) are often
regarded with some negativity because of the assumption of punishment, control and …

Aims: To examine medication adherence and discontinuation in two separate groups of
patients with schizophrenia or bipolar disorder (BD), who began receiving a long-acting …

This mirror-image study aimed to evaluate the real-life effectiveness of long-acting injectable
antipsychotics (LAI) in schizophrenia. Patients with schizophrenia initiating LAIs January …

Shared decision-making (SDM) is a process in which the doctor provides clear and
complete medical information to patients about their treatment, and patients provide …

Schizophrenia is a serious mental illness that requires continuous and effective long-term
management to reduce symptoms, improve quality of life, and prevent relapse. Oral …

An important step to improve outcomes for patients with schizophrenia is to understand
treatment patterns in routine practice. The aim of the current study was to describe the long …

Abstract Long-Acting Injectable Antipsychotics (LAIs) are used to overcome non-compliance
in psychoses, mainly schizophrenia spectrum disorders. We aimed to summarize available …